Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 2,650 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pilot Group Clear all

Conditions: Hyperlipidemia
Interventions: Aspirin, Placebo, Niacin; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Liver Cancer
Interventions: Drug Eluting Bead Transarterial Chemoembolization, Nivolumab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 9
States / cities: St Louis, Missouri • Basking Ridge, New Jersey • Middletown, New Jersey + 6 more

Conditions: Mental Health Strategies, School Mental Health Services, Digital Technologies, Technology Development
Interventions: ASSIST-MH; Other
Lead sponsor: 3-C Institute for Social Development; Industry
Eligibility: 12 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Overweight Adolescents, Obese Adolescents
Interventions: Emotion regulation and self-monitoring to treat pediatric obesity, Psychoeducation; Behavioral · Other
Lead sponsor: Texas Tech University; Other
Eligibility: 11 Years to 14 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Fragile X Syndrome, Autism Spectrum Disorders
Interventions: Acamprosate; Drug
Lead sponsor: Indiana University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Mild Dementia, Moderate Dementia
Interventions: 5+1 Adapted, early-stage dyadic care planning intervention, Counseling session and printed resources; Behavioral
Lead sponsor: Benjamin Rose Institute on Aging; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Opioid Use Disorder
Interventions: Wiidookaage'win Facebook Group; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Vaping, Social Support
Interventions: Quit the Hit (QTH) Program with Peer Mentoring; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 29 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Maternal Psychological Distress, Perinatal Depression, Self-Regulation, Emotion
Interventions: Trauma Informed Prenatal Intervention (TPI), Prenatal Education Topics; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer
Interventions: celecoxib, oophorectomy; Drug · Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Chronic Pain
Interventions: PainCare VR, Audio content; Device · Other
Lead sponsor: AppliedVR Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cervical Cancer
Interventions: Introducer "calla" device, Interviews only; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 305 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Low Back Pain (CLBP)
Interventions: Osteopathic Manipulative Treatment; Other
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Dementia Severe
Interventions: AMUSED, Reading Aloud; Behavioral
Lead sponsor: Alaine E Hernandez, PhD; Other
Eligibility: 65 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Cynthiana, Kentucky • Danville, Kentucky • Lexington, Kentucky + 3 more

Conditions: Spine Surgery
Interventions: Postoperative methadone, Postoperative placebo, Rescue Analgesia; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sickle Cell Disease, Executive Dysfunction, Cognitive Impairment, Attention Deficit/Hyperactivity Disorder (ADHD)
Interventions: Extended-Release Methylphenidate; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Chronic Subdural Hematoma
Interventions: Minimally Invasive Cortical Access System (MICAS); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 55 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy
Interventions: Motor imagery training, NO motor imagery training; Other
Lead sponsor: Ahmed Mahmoud Kadry; Other
Eligibility: 18 Years to 35 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Mequon, Wisconsin

Conditions: Physical Inactivity
Interventions: MAP to Health; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 40 Years to 64 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Ankle Fractures
Interventions: Telerehabilitation, Standard rehabilitation; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Hidradenitis Suppurativa (HS)
Interventions: Mindfulness-Based Stress Reduction; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Healthy
Interventions: Dry needling; Procedure
Lead sponsor: Florida Gulf Coast University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Hobart, Indiana

Conditions: Medication Adherence
Interventions: 5 Behavioral Change Techniques; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Bronchiolitis
Interventions: NoseFrida; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 2 Months to 2 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Biosynthesis of PGD2 in Vivo

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Assist MH Digital Technologies to Support School Mental Health Care

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Acamprosate in Youth With Fragile X Syndrome

SHARE Adaptation Intervention for African-American Families

Using Facebook to Support Opioid Recovery Among American Indian Women

Social Media Vaping Cessation Pilot With Peer Mentors

Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Self-Administered Skills-Based Virtual Reality Intervention for Chronic Pain

Pilot Study for Speculum Free Cervical Cancer Screening

How Osteopathic Treatment Affects the Leg and Foot in People With Low Back Pain

A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia

Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation

The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults

MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults

Telerehabilitation Following Ankle Fractures

Acceptability of MBSR for People With HS

Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System

Reducing African-American CVD Disparities Intervention Optimization (RADIO) Individuals on Statins

Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study